(R)-8-Chloro-1-Methyl-2,3,4,5-Tetrahydro-1H-3-Benzazepine Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic routes for serotonin-2C receptor agonists, such as lorcaserin hydrochloride, are not efficient enough for the treatment of obesity and central nervous system disorders, necessitating the development of new and more efficient processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its intermediates.
Innovation Solution
The development of processes for preparing amide compounds, dihydrooxazole compounds, and amino alcohol compounds, including specific reaction pathways involving phenylacetic acid derivatives, amines, coupling reagents, and reducing agents, to produce (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its solid forms, which are useful as serotonin-2C receptor agonists.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current synthetic routes are used for serotonin-2C receptor agonists, then the existing production method is maintained, but the efficiency is insufficient for treating obesity and central nervous system disorders
Solution Approach 1:
The synthetic route is divided into distinct segments: Step 1 forms the amide compound (1-3) from phenylacetic acid derivative (1-1) and amine (1-2); Step 2 reduces the amide to amino alcohol (2-1); Step 3 converts to dichloro compound (3-1); Step 4 cyclizes to form the final benzazepine product (3-2). This segmentation allows optimization of each step independently, improving overall synthetic efficiency and reducing development time.
Solution Approach 2:
The patent performs preliminary actions by preparing specific intermediates with predetermined structures and properties before final assembly. The phenylacetic acid derivative (1-1) and amine (1-2) are prepared in advance with specific substituents (R1, R2, R3, R4, R5, R6) that will determine the final product's pharmacological properties, allowing for systematic optimization of the synthetic pathway.
2Productivity
If new synthetic processes are developed for (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, then synthetic efficiency is improved, but process complexity increases
Solution Approach 1:
The patent optimizes reaction parameters at each step: Step 1 uses coupling reagents with specific conditions; Step 2 employs reducing agents with controlled stoichiometry and temperature; Step 3 uses chlorinating agents with specific pH control; Step 4 utilizes cyclization conditions with precise temperature and time parameters. These parameter optimizations improve efficiency while maintaining manageable process complexity through systematic control.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These processes provide effective intermediates and compounds for the treatment of obesity and central nervous system disorders, offering improved efficiency and potential for therapeutic applications.
Implementation Method 1
reacting a phenylacetic acid derivative compound of Formula 1-1 with an amine compound of Formula 1-2 in the presence of a coupling reagent to afford an amide compound of Formula 1-3
Implementation Method 2
reacting the amide compound of Formula 1-3 with a reducing agent to afford an amino alcohol compound of Formula 2-1
Data Source
AI summary
The present invention provides processes and intermediates for the preparation of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and salts thereof which are useful as serotonin-2C (5-HT2C) receptor agonists for the treatment of, for example, obesity.